Campbell Newman Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.44M | Buy |
|
|||||
|
2025
Q1 | $1.39M | Sell |
|
|||||
|
2024
Q4 | $1.55M | Sell |
|
|||||
|
2024
Q3 | $1.34M | Sell |
|
|||||
|
2024
Q2 | $1.17M | Buy |
|
|||||
|
2024
Q1 | $1.48M | Buy |
|
|||||
|
2023
Q4 | $1.23M | Buy |
|
|||||
|
2023
Q3 | $1.17M | Buy |
|
|||||
|
2023
Q2 | $778K | Buy |
|
|||||
|
2023
Q1 | $917K | Buy |
|
|||||
|
2022
Q4 | $895K | Buy |
|
|||||
|
2022
Q3 | $822K | Buy |
|
|||||
|
2022
Q2 | $686K | Buy |
|
|||||
|
2022
Q1 | $734K | Buy |
|
|||||
|
2021
Q4 | $649K | Buy |
|
|||||
|
2021
Q3 | $578K | Buy |
|
|||||
|
2021
Q2 | $635K | Buy |
|
|||||
|
2021
Q1 | $511K | Buy |
|
|||||
|
2020
Q4 | $468K | Buy |
|
|||||
|
2020
Q3 | $359K | Buy |
|
|||||
|
2020
Q2 | $402K | Buy |
|
|||||
|
2020
Q1 | $302K | Sell |
|
|||||
|
2019
Q4 | $416K | Sell |
|
|||||
|
2019
Q3 | $483K | Sell |
|
|||||
|
2019
Q2 | $586K | Buy |
|
|||||
|
2019
Q1 | $581K | Buy |
|
|||||
|
2018
Q4 | $537K | Buy |
|
|||||
|
2018
Q3 | $730K | Buy |
|
|||||
|
2018
Q2 | $823K | Buy |
|
|||||
|
2018
Q1 | $601K | Buy |
|
|||||
|
2017
Q4 | $500K | Buy |
|
|||||
|
2017
Q3 | $410K | Buy |
|
|||||
|
2017
Q2 | $385K | Buy |
|
|||||
|
2017
Q1 | $267K | Buy |
|